Neurobiological Technologies, Inc.
NTII · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,842 | $8,230 | $27,941 | $5,538 |
| Short-Term Investments | $738 | $15,819 | $2,039 | $3,366 |
| Receivables | $0 | $184 | $599 | $483 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $305 | $280 | $862 |
| Total Curr. Assets | $2,580 | $24,538 | $30,859 | $10,249 |
| Property Plant & Equip (Net) | $0 | $70 | $393 | $588 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $11,850 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $52 | $85 | $84 |
| Total NC Assets | $0 | $122 | $12,328 | $672 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,580 | $24,660 | $43,187 | $10,921 |
| Liabilities | – | – | – | – |
| Payables | $5 | $21 | $588 | $1,623 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $5,500 | $5,500 |
| Other Curr. Liab. | $68 | $1,094 | $2,954 | $7,099 |
| Total Curr. Liab. | $73 | $1,115 | $9,042 | $14,222 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $13,292 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $967 | $0 | $567 | $18,792 |
| Total NC Liab. | $967 | $0 | $13,859 | $18,792 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,040 | $1,115 | $22,901 | $33,014 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $247 | $247 | $247 |
| Common Stock | $0 | $27 | $27 | $33 |
| Retained Earnings | $0 | -$122,468 | -$125,591 | -$109,269 |
| AOCI | $1,540 | $0 | $490 | -$6 |
| Other Equity | $0 | $145,739 | $145,113 | $86,902 |
| Total Equity | $1,540 | $23,545 | $20,286 | -$22,093 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,580 | $24,660 | $43,187 | $10,921 |
| Net Debt | -$1,842 | -$8,230 | -$27,941 | -$5,538 |